The role of EGFR activation has been well studied in cancer angiogenesis and proliferation of cancer cells, and EGFR antagonists and/or blocking antibodies are used to treat, or are being studied as treatments for, certain types of cancers (Agustoni et al., 2019; Santos et al., 2021). The gene discussed is EGFR; the disease is cancer.